Log In
BCIQ
Print this Print this
 

JCAR018

  Manage Alerts
Collapse Summary General Information
Company Juno Therapeutics Inc.
DescriptionAutologous T cells expressing a chimeric antigen receptor (CAR) specific to the CD22 antigen
Molecular Target CD22
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$150.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/29/2015

Undisclosed

$150.2M

0

Get a free BioCentury trial today